BREAKING NEWS

BeyondSpring announces submission of New Drug Application (NDA) to U.S. FDA and China NMPA for Plinabulin and G-CSF combination for the prevention of chemotherapy-induced neutropenia (CIN).
Read more

stock overview

Stock Overview

As we lead with promising and innovative therapeutic solutions, our positive influence is also being recognized across financial and industry markets.

Stock Quote

BYSI (Common Stock)

  • Price
  • 9.44
  • Change
  • 0.07

  • Intraday High
  • 9.51
  • 52 Week High
  • 21.5

  • Intraday Low
  • 9.24
  • 52 Week Low
  • 9.55

  • Today's Open
  • 9.47
  • Currency
  • USD

  • Previous Close
  • 9.37
  • Exchange
  • NASDAQ NMS - GLOBAL MARKET

Date Requested
April 20, 2021
Open Price
9.52
Closing Price
9.37
Day High
9.73
Day Low
9.25
Volume
179391

NOTE: The Closing Price, Day’s High, Day’s Low, and Day’s Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above. The Actual Price is not adjusted for splits or dividends. The closing price above is not necessarily indicative of future price performance.